Effect of timing of pegfilgrastim administration on absolute neutrophil count (ANC) trajectory among cancer patients (pts) receiving myelosuppressive chemotherapy (chemo).

被引：0
|
作者：
Li, Yanli
Klippel, Zandra Karina
Shih, Xiaolong
Wang, Hong
Reiner, Maureen
Page, John
机构：
[1] Amgen Inc, San Francisco, CA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] SimulStat Inc, San Diego, CA USA
[4] TechData Serv Co LLC, King Of Prussia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20674
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Serum pegfilgrastim concentrations during recovery of absolute neutrophil count in patients with cancer receiving pegfilgrastim after chemotherapy
    Yang, Bing-Bing
    Kido, Anna
    Shibata, Atsuko
    PHARMACOTHERAPY, 2007, 27 (10): : 1387 - 1393
  • [2] The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy
    Lyman, G. H.
    Reiner, M.
    Morrow, P. K.
    Crawford, J.
    ANNALS OF ONCOLOGY, 2015, 26 (07) : 1452 - 1458
  • [3] Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim
    Xu, H.
    Gong, Q.
    Vogl, F. D.
    Reiner, M.
    Page, J. H.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (02) : 723 - 730
  • [4] Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim
    H. Xu
    Q. Gong
    F. D. Vogl
    M. Reiner
    J. H. Page
    Supportive Care in Cancer, 2016, 24 : 723 - 730
  • [5] Absolute neutrophil count (ANC) pattern with accelerated dose-intensified epirubicin chemotherapy and pegfilgrastim support
    Segota, E
    Misbah, S
    Crowe, J
    Tubbs, R
    Casey, G
    Elson, P
    Wacker, B
    Budd, GT
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 786S - 786S
  • [6] Risk of febrile neutropenia (FN) in cancer patients (pts) receiving myelosuppressive chemotherapy and pegfilgrastim prophylaxis (PEG-P): Does day of administration matter?
    Weycker, Derek
    Li, Xiaoyan
    Barron, Richard L.
    Figueredo, Jacqueline
    Hagiwara, May
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] ABSOLUTE NEUTROPHIL COUNTS IN A STUDY OF LIPEGFILGRASTIM COMPARED WITH PEGFILGRASTIM IN PATIENTS WITH BREAST CANCER WHO ARE RECEIVING CHEMOTHERAPY
    Gladkov, O. A.
    Bondarenko, I. M.
    Elsaesser, R.
    Buchner, A.
    Bias, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 500 - 500
  • [8] Risk Factors For Bone Pain Among Patients Receiving Myelosuppressive Chemotherapy and Primary Prophylactic Pegfilgrastim
    Xu, Hairong
    Gong, Qi
    Vogl, Florian D.
    BLOOD, 2013, 122 (21)
  • [9] Trajectory of absolute neutrophil counts in patients treated with pegfilgrastim on the day of chemotherapy versus the day after chemotherapy
    Li, Yanli
    Klippel, Zandra
    Shih, Xiaolong
    Wang, Hong
    Reiner, Maureen
    Page, John H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 703 - 712
  • [10] Trajectory of absolute neutrophil counts in patients treated with pegfilgrastim on the day of chemotherapy versus the day after chemotherapy
    Yanli Li
    Zandra Klippel
    Xiaolong Shih
    Hong Wang
    Maureen Reiner
    John H. Page
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 703 - 712
12345